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Signs and Symptoms
•
•
•
•
•

•

Signs and symptoms of gout start with an elevation in
serum uric acid levels greater than 6.8 mg/dl.
Four clinical manifestations are seen in gout:
asymptomatic hyperuricemia, acute gout, intercritical
gout, and chronic advanced gout.
Symptoms occur when elevated uric acid in the
bloodstream creates urate crystals triggering a gout
flare.
A flare is an acute onset within 24 hours with extremely
painful mono or oligoarthritis, which often results in sick
leave.
Higher uric acid levels predict more flares and
development of tophi. Tophi are an accumulation of
monosodium urate crystals that can form swollen areas
in the joints, cartilage, bones, and skin nodules.
Hyperuricemia can be non-symptomatic but typically
precedes gout.

Significance of Pathophysiology
Introduction
Gout is a syndrome caused by an inflammatory response
creating an over production of uric acid increasing uric acid
levels in the blood and body fluids. Gout is defined as a
disorder resulting from tissue deposition of MSU crystals
(in joints, bursae, bone, and certain other soft tissues, such
as ligaments, tendons and occasionally, skin) and/or
crystallization of uric acid within the renal collecting
system (tubules and renal pelvis) that typically occurs in
acid urine” (Terkeltaub & Edwards, 2013, p. 20). Gout is
among the oldest diseases affecting approximately 3.9% of
adults in America (Terkeltaub & Edwards, 2013, p. xv).
Historically, Gout was the “disease of kings.” An early
century caricature depicts gout in affluent middle-aged
men that over indulge in alcohol and food. Today, the
population stereotypes the average patient with
impressions of self-limiting behavior such as drinking and
diet (Terkeltaub & Edwards, 2013, p. xv). Gout prevalence
and incidence are on the rise. Gout pathophysiology is
complex and not easily understood affecting the patients’
quality of life. Gout treatment is associated with treatment
failure and noncompliance. Consequently, “Most patients
with gout are treated in general practice and never enter
the domain of the rheumatologist, and general
practitioners (GPs) are unlikely to read guidelines that are
published in rheumatology journals or present on
rheumatology websites” (Perry & Madhok, 2010, p. 2233).
Increasing knowledge and understanding of gout, clinicians
can significantly influence the quality of life through
treatment options for patients and practitioners.

Implications for Nursing Care

Asymptomatic Hyperuricemia
Hyperuricemia can be non-symptomatic but typically precedes
gout. Asymptomatic gout is associated with lower uric acid levels.
Asymptomatic gout is the elevation of uric acid in the blood with
no clinical symptoms. Silent tissue deposits of urate may be
present. Gout affects the lower extremities often at night and may
present as an itchy feeling.
Acute Intermittent Gout
Acute gout attacks are usually sudden, nocturnal and triggered by
alcohol intake, dehydration, joint injury recent surgery, and fever.
Acute gout treatments priority is to relieve the acute symptoms by
reducing inflammation and reducing serum urate. Medications
include NSAIDS, oral colchicine, and corticosteroids.
The classic presentation is podagra, 90% of patient have this
inflammation of the first metatarsophalangeal joint of the foot.
Lower extremity joints are most common for initial gout attacks.
Acute gouty arthritis results from increased uric acid levels that
cause monosodium urate crystals (MSU) to deposit in the joints.
MSU attract leukocytes to the synovial space where the MSU
crystals get phagocytized and destructive enzymes cause further
inflammation and tissue damage (Hardy, 2011, p. 14).
Patients may have systemic symptoms such as low grade fever,
chills, and malaise. Laboratory data may reveal elevated
sedimentations rate and leukocytosis.
Intercritical gout is when acute gouty arthritis returns to an
asymptomatic phase.
Advanced Gout
Untreated gout will progress to advanced gout. Intercritical
periods disappear and patient develops chronic arthritis due to
tophi causing synovial inflammation making joints painful and
swollen. Chronic tophaceous gout is a cycle of attacks that over
time, attacks will occur more frequently, affect more joints and last
longer. “Some 60% of patients will have a second attack in the first
year, and 78% will have a second attack within two years” (Hardy,
2011, p. 14)

•

Patients with gout show reduced health related quality of life exhibit reduced social
functioning due to pain, limited activity, and immobility. Quick treatment of acute gout
flares and prevention of subsequent attacks is essential, “subjects perception of their
overall gout related pain and functioning were highly correlated with HRQOL and
disability” (Smith, Bracken, & Smith, 2011, p. 1114).

•

Improving outcomes in the management of gout necessitates the nurse to become
knowledgeable of the stages of gout including treatment goals and treatment
complications. Nursing strategies includes detecting risk factors, identifying predisposing
factors, and recognizing symptoms. Nurses educate patients on acute attacks, preventing
attacks, dietary modification, and general considerations of gout through all four stages.
Gout is on the rise and affects approximately 3 to 5 million people in the United States
(Hardy, 2011, p. 14). Due to the sporadic nature of gout, identifying risk factors is essential
to improving outcomes.

•

Risk factors include advanced age, male gender, postmenopausal female gender, drugs
(diuretics, low-dose aspirin, cyclosporine), hypertension, high alcohol intake, high body
mass index, diet high in meat and seafood, and genetic influences (Vannucchi, 2012). With
only “approximately 20% of patients will make lifestyle changes” (Hardy, 2011, p. 19),
increasing the need for nurses to education about joint destruction during the intercritical
periods is critical. Advance practice nurses identify that gout may be a sign of other
comorbidities such as diabetes mellitus, hypertension, renal manifestations, obesity,
metabolic syndrome, heart failure, hyperlipidemia, and cardiovascular disease.

•

Rheumatologists are specialist trained in the acute and chronic management of gout.
Hardy (2011) states that studies show that gout is a common cause for inpatient
rheumatologist referrals, and primary care physicians refer only 3% of patients to a
rheumatologist (p. 19). The American College of Rheumatology established treatment
guidelines to set a standard for the treatment of gout. Crittenden & Pillinger (2013)
identify gout treatment guidelines including dietary considerations, treatment of acute
gout attacks, lowering urate in established gout patient, preventative treatment, and
seeking expert guidance. Non-pharmacological treatment of gout includes applying ice and
resting the joints.

•

Pharmacologic treatment includes non-steroidal anti-inflammatory drugs, urate lower
drugs, glucocorticoids, intra-articular steroid with careful consideration to coexisting illness
and severity of symptoms. Advanced practice nurses educate and monitor the gout patient
for adverse side effects associated with gout treatment. Key strategies focus on mediation
compliance, potential side effects, and contraindications.

Clinical example excision of
gouty tophi
Underlying Pathophysiology
Symptoms occur when elevated uric acid in the bloodstream
creates urate crystals that deposit in the joints or tendons causing
inflammation. Inflammatory cytokines and neutrophils trigger by
the immune response from crystal deposits in the joints. “MSU
crystals deposit into tophi typically in cool, poorly vascularized
peripheral connective tissue” (Terkeltaub & Edwards, 2013, p. 43)
Uric acid is the byproduct of purine catabolism generated from
the activity of xanthine oxidase (Zychowicz, Pope, & Graser, 2010,
p. 624). Purines are chemicals found in the human body obtained
through the diet. “Evolutionary loss of functional uricase, the
enzyme that converts uric acid to the more soluble allantoin in
most other mammals, causes hyperuricemia risks in humans”
(Zychowicz et al., 2010, p. 624). Hyperuricemia occurs from an
overproduction of uric acid (10%) or urate under-excretion (90%)
by the kidneys. Inherited mutations in renal urate transporters,
acquired kidney disease, hypertension, insulin resistance
(metabolic syndrome), high alcohol intake, lead toxicity,
medications are contributing factors to inefficient renal excretion
of uric acid (Terkeltaub & Edwards, 2013, table 1.3). Genetic
disorders, disorders of increased cell turnover, and diet result in
overproduction of uric acid (Terkeltaub & Edwards, 2013, table
1.3). The clinical presentation of gout is monoarticular pain and
swelling in the lower extremities especially the great toe. Patients
complain of symptoms more often at night with a duration of 3 to
10 days before seeking treatment (Hardy, 2011, p. 14). Treatment
goals are to reduce gout flare, protect against future attacks, and
lower serum urate.

Conclusion
Gout tends to be undertreated and on the rise. Poor patient understanding, physician failure to
develop targeted treatment plans, and failure of therapies are reasons for inadequate gout
treatments. Nurses play a significant role in improving outcomes for the identification and
management of gout through education, collaboration, and compliance. Gout patients add
significantly to national health care costs in gout patients with more frequent attack. Acute gout
symptoms encourage patients to seek treatment due to pain. Intercritical periods reduce
medication compliance and dietary management resulting in increased risk of tophi development
and acute gouty attacks. Routine follow up is essential to achieve treatment goals. Nurses
sensitize the patient on the lifelong compliance of urate-lowering medications, dietary
restrictions, and the importance of maintaining a healthy weight through diet and exercise.
Nurses are essential to improve the patients’ quality of life but also improving utilization of
health care resources.
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